₹6,400.00 Original price was: ₹6,400.00.₹4,499.00Current price is: ₹4,499.00.
The Neuron-Specific Enolase (NSE) test measures the level of NSE, an enzyme found in neuronal and neuroendocrine cells. This test is primarily used as a tumor marker and in evaluating neurological disorders.
✅ Cancer Diagnosis & Monitoring:
✅ Neurological Conditions:
✅ Assess Hypoxic Brain Injury (e.g., after cardiac arrest)
🔬 Sample Type: Blood (Serum/Plasma) or CSF (Cerebrospinal Fluid)
📌 NSE levels in CSF are more specific for neuronal damage than in blood.
| NSE Level (ng/mL) | Interpretation | Possible Causes |
|---|---|---|
| <12 ng/mL | Normal | No significant neuronal injury or tumor presence |
| 12-25 ng/mL | Mild elevation | Possible mild neuronal injury (e.g., stroke, TBI) |
| >25 ng/mL | Significantly elevated | Suggestive of SCLC, neuroblastoma, severe brain damage |
📌 A rising NSE level in cancer patients suggests tumor progression or recurrence.
📌 A decreasing NSE level after treatment indicates a positive response.
⚠ NSE is NOT a standalone diagnostic tool – It should be interpreted along with imaging and clinical findings.
⚠ Hemolysis (ruptured red blood cells) can falsely elevate NSE – Proper sample handling is crucial.
⚠ Other conditions (e.g., chronic kidney disease, hemolytic diseases) can mildly raise NSE levels.
🔬 If elevated:
✔ Further testing with CT/MRI, PET scans for cancer or neurological damage
✔ Monitor serial NSE levels in cancer patients to track treatment response